Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.
Scope of the Report:
This report focuses on the Combined Hormonal Contraceptives in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The worldwide market for Combined Hormonal Contraceptives is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Actavis
Agile Therapeutics
Allergan
Bayer
Teva Pharmaceutical Industries
ANI Pharmaceuticals
Ortho-McNeil-Janssen Pharmaceuticals
Noven Pharmaceuticals
Johnson & Johnson
Mylan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
15-24 years
25-34 years
35-44 years
Above 44 years
Market Segment by Applications, can be divided into
Hospitals
Household
Clinics
There are 15 Chapters to deeply display the global Combined Hormonal Contraceptives market.
Chapter 1, to describe Combined Hormonal Contraceptives Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Combined Hormonal Contraceptives, with sales, revenue, and price of Combined Hormonal Contraceptives, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Combined Hormonal Contraceptives, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Combined Hormonal Contraceptives market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Combined Hormonal Contraceptives sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Combined Hormonal Contraceptives Introduction
1.2 Market Analysis by Type
1.2.1 15-24 years
1.2.2 25-34 years
1.2.3 35-44 years
1.2.4 Above 44 years
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Household
1.3.3 Clinics
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Actavis
2.1.1 Business Overview
2.1.2 Combined Hormonal Contraceptives Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Actavis Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Agile Therapeutics
2.2.1 Business Overview
2.2.2 Combined Hormonal Contraceptives Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Allergan
2.3.1 Business Overview
2.3.2 Combined Hormonal Contraceptives Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Allergan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bayer
2.4.1 Business Overview
2.4.2 Combined Hormonal Contraceptives Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Bayer Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharmaceutical Industries
2.5.1 Business Overview
2.5.2 Combined Hormonal Contraceptives Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 ANI Pharmaceuticals
2.6.1 Business Overview
2.6.2 Combined Hormonal Contraceptives Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Ortho-McNeil-Janssen Pharmaceuticals
2.7.1 Business Overview
2.7.2 Combined Hormonal Contraceptives Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Noven Pharmaceuticals
2.8.1 Business Overview
2.8.2 Combined Hormonal Contraceptives Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Johnson & Johnson
2.9.1 Business Overview
2.9.2 Combined Hormonal Contraceptives Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mylan
2.10.1 Business Overview
2.10.2 Combined Hormonal Contraceptives Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mylan Combined Hormonal Contraceptives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Combined Hormonal Contraceptives Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Combined Hormonal Contraceptives Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Combined Hormonal Contraceptives Manufacturer Market Share in 2017
3.3.2 Top 6 Combined Hormonal Contraceptives Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Combined Hormonal Contraceptives Market Analysis by Regions
4.1 Global Combined Hormonal Contraceptives Sales, Revenue and Market Share by Regions
4.1.1 Global Combined Hormonal Contraceptives Sales and Market Share by Regions (2013-2018)
4.1.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Regions (2013-2018)
4.2 North America Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
4.3 Europe Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
4.5 South America Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
5 North America Combined Hormonal Contraceptives by Countries
5.1 North America Combined Hormonal Contraceptives Sales, Revenue and Market Share by Countries
5.1.1 North America Combined Hormonal Contraceptives Sales and Market Share by Countries (2013-2018)
5.1.2 North America Combined Hormonal Contraceptives Revenue and Market Share by Countries (2013-2018)
5.2 United States Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
5.3 Canada Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
5.4 Mexico Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
6 Europe Combined Hormonal Contraceptives by Countries
6.1 Europe Combined Hormonal Contraceptives Sales, Revenue and Market Share by Countries
6.1.1 Europe Combined Hormonal Contraceptives Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Combined Hormonal Contraceptives Revenue and Market Share by Countries (2013-2018)
6.2 Germany Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
6.3 UK Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
6.4 France Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
6.5 Russia Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
6.6 Italy Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
7 Asia-Pacific Combined Hormonal Contraceptives by Countries
7.1 Asia-Pacific Combined Hormonal Contraceptives Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Combined Hormonal Contraceptives Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Combined Hormonal Contraceptives Revenue and Market Share by Countries (2013-2018)
7.2 China Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
7.3 Japan Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
7.4 Korea Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
7.5 India Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
8 South America Combined Hormonal Contraceptives by Countries
8.1 South America Combined Hormonal Contraceptives Sales, Revenue and Market Share by Countries
8.1.1 South America Combined Hormonal Contraceptives Sales and Market Share by Countries (2013-2018)
8.1.2 South America Combined Hormonal Contraceptives Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
8.3 Argentina Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
8.4 Colombia Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
9 Middle East and Africa Combined Hormonal Contraceptives by Countries
9.1 Middle East and Africa Combined Hormonal Contraceptives Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Combined Hormonal Contraceptives Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Combined Hormonal Contraceptives Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
9.3 UAE Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
9.4 Egypt Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
9.5 Nigeria Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
9.6 South Africa Combined Hormonal Contraceptives Sales and Growth Rate (2013-2018)
10 Global Combined Hormonal Contraceptives Market Segment by Type
10.1 Global Combined Hormonal Contraceptives Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Combined Hormonal Contraceptives Sales and Market Share by Type (2013-2018)
10.1.2 Global Combined Hormonal Contraceptives Revenue and Market Share by Type (2013-2018)
10.2 15-24 years Sales Growth and Price
10.2.1 Global 15-24 years Sales Growth (2013-2018)
10.2.2 Global 15-24 years Price (2013-2018)
10.3 25-34 years Sales Growth and Price
10.3.1 Global 25-34 years Sales Growth (2013-2018)
10.3.2 Global 25-34 years Price (2013-2018)
10.4 35-44 years Sales Growth and Price
10.4.1 Global 35-44 years Sales Growth (2013-2018)
10.4.2 Global 35-44 years Price (2013-2018)
10.5 Above 44 years Sales Growth and Price
10.5.1 Global Above 44 years Sales Growth (2013-2018)
10.5.2 Global Above 44 years Price (2013-2018)
11 Global Combined Hormonal Contraceptives Market Segment by Application
11.1 Global Combined Hormonal Contraceptives Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Household Sales Growth (2013-2018)
11.4 Clinics Sales Growth (2013-2018)
12 Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.1 Global Combined Hormonal Contraceptives Sales, Revenue and Growth Rate (2018-2023)
12.2 Combined Hormonal Contraceptives Market Forecast by Regions (2018-2023)
12.2.1 North America Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.2.2 Europe Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.2.3 Asia-Pacific Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.2.4 South America Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.2.5 Middle East and Africa Combined Hormonal Contraceptives Market Forecast (2018-2023)
12.3 Combined Hormonal Contraceptives Market Forecast by Type (2018-2023)
12.3.1 Global Combined Hormonal Contraceptives Sales Forecast by Type (2018-2023)
12.3.2 Global Combined Hormonal Contraceptives Market Share Forecast by Type (2018-2023)
12.4 Combined Hormonal Contraceptives Market Forecast by Application (2018-2023)
12.4.1 Global Combined Hormonal Contraceptives Sales Forecast by Application (2018-2023)
12.4.2 Global Combined Hormonal Contraceptives Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Combined Hormonal Contraceptives Picture
Table Product Specifications of Combined Hormonal Contraceptives
Figure Global Sales Market Share of Combined Hormonal Contr